Regeneron patent anti-ANGPTL8 (anti-ANGPTL8) is a monoclonal antibody againts Angiopoietin-like protein (ANGPTL8) with potential to treat hypertriglyceridemia.
规格
产品名称
Regeneron patent anti-ANGPTL8 (anti-ANGPTL8)
别名
ANGPTL8抗体 | ANGPTL8单克隆抗体 | ANGPTL8药靶抗体
英文别名
Angiopoietin-like protein 8 antibody | ANGPTL8 antibody | betatrophin antibody | Chromosome 19 open reading frame 80 antibody | hepatocellular carcinoma-associated gene TD26 antibody | Hepatocellular carcinoma-associated protein TD26 antibody | Lipasin an
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
图片
Regeneron patent anti-ANGPTL8 (anti-ANGPTL8) (Ab209779) - ELISA Immobilized Recombinant hu-ANGPTL8-hFc protein at 2.0 μg/mL can bind Regeneron patent anti-ANGPTL8 (anti-ANGPTL8) (Ab209779).
Regeneron patent anti-ANGPTL8 (anti-ANGPTL8) (Ab209779) - SEC The purity of Regeneron patent anti-ANGPTL8 (anti-ANGPTL8) (Ab209779) is more than 95% verified by HPLC.